Clinical Trial Update: Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two new formulations to Gynomax XL Ovule for treatment of vaginal infections; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis
• Candidal Vulvovaginitis
• Mixed Vaginal Infections
• Trichomonal Vaginitis

Drugs mentioned

• Gynomax XL Ovule

Snippet

Sponsor: Ege University | Conditions: Trichomonal Vaginitis, Bacterial Vaginosis | Phase 3 | Status: COMPLETED